Modern implant-based reconstruction increasingly uses two technologies together: a biological matrix to support the implant and processed fat to refine the result. This article explains how ExaShape and ExaFat combine in a prepectoral approach. It is general information, not clinical guidance.

Two problems, two tools

Muscle-sparing prepectoral reconstruction places the implant above the muscle, which solves the problems of animation deformity and muscle pain but creates two new needs: support and coverage for the implant, and enough soft-tissue quality over it. ExaShape addresses the first; ExaFat supports the second.

The matrix: structure and integration

ExaShape wraps and supports the implant, defines the pocket and is engineered to be repopulated and revascularised so it becomes living tissue — carrying the mechanical role the muscle would otherwise play.

The fat: refinement and coverage

With the implant sitting closer to the skin, soft-tissue quality matters. Cleaner, better-preserved fat from ExaFat adds natural coverage, softens contours and improves the transition between the reconstruction and the chest — the finishing layer of a natural result.

Why the combination is more than the sum

Together they express the med-tech philosophy: not simply replacing what was removed, but helping the body rebuild vascularised, integrated tissue. Structure and soft tissue are addressed as one plan rather than two afterthoughts.

The bottom line

ExaShape and ExaFat pair a supporting, integrating matrix with cleaner grafting fat to enable muscle-sparing, biology-led prepectoral reconstruction. Explore both in the ABC portfolio.

This article is general information, not clinical guidance. Refer to each device’s instructions for use and current evidence; suitability is a clinical decision.